• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/3

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

3 Cards in this Set

  • Front
  • Back
Accelerated phase of CML
increase count
splenomegaly
increased left shift
intensive therapy
increased blasts but < 20%
Imatinib
Use: treatment of CML
MOA: works by competing with ATP for binding to kinase catlytic domain
SFx: edema (70%), nausea (70%) & vomiting (54%),
diarrhea (50%), cramps (46%), myelosuppression (30%),
possibly cardiotoxicity

Resistance: point mutation in Abl kinase domain (T315l). Overproduction of BCR-ABL
Treatment of CML
imatinib